<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="111135">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02147665</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00031150</org_study_id>
    <nct_id>NCT02147665</nct_id>
  </id_info>
  <brief_title>Effects of Hookah Smoking on Blood Flow to the Heart, Muscle and Skin</brief_title>
  <official_title>Effects of Hookah Smoking on Blood Flow to the Heart, Muscle and Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cedars-Sinai Medical Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study on acute effects of Hookah smoking on the sympathetic neural control
      of the human cardiovascular system. Hookah smoking is known to transiently increase blood
      pressure and heart rate while decreasing heart rate variability suggesting - but not proving
      - sympathetic mediation. Here the investigators will directly measure the acute effects of
      Hookah smoking on sympathetic nerve activity with microneurography (intraneural
      microelectrodes) and quantify associated regional changes in vasomotor tone.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Sympathetic nerve activity</measure>
    <time_frame>At the initial study visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>Multi-unit recordings of sympathetic nerve activity will be obtained with single-use sterile tungsten microelectrodes inserted selectively into muscle or skin nerve fascicles of the peritoneal nerve.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial contrast echocardiography</measure>
    <time_frame>At the initial study visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>Myocardial contrast echocardiography will be used to measure regional myocardial perfusion (i.e. capillary blood volume) and coronary flow reserve.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Venous Occlusion Plethysmography</measure>
    <time_frame>At the initial study visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>Lower leg blood flow will be measured with standard venous occlusion plethysmography.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hookah Smoking</condition>
  <arm_group>
    <arm_group_label>Hookah smoking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy habitual Hookah smokers will undergo microneurography, myocardial contrast echocardiogram or venous occlusion plethysmography before and after Hookah smoking.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hookah smoking</intervention_name>
    <description>Subjects will smoke waterpipe in a controlled research environment.</description>
    <arm_group_label>Hookah smoking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 39 years of age

          -  Habitual Hookah smoker defined as having smoked Hookah &gt;=12 times in the  past 12
             months

          -  Have not smoked cigarettes within the past 12 months

        Exclusion Criteria:

          -  Exhaled carbon monoxide level greater than 10 ppm* as evidence of current or recent
             cigarette (excluded if smoked cigarette within 12 months) or Hookah smoking (excluded
             if smoked Hookah within past 72 hours)

          -  History of cardiopulmonary disease

          -  Use of any prescription medication with exception of oral contraceptive pills

          -  History of psychiatric illness

          -  History of neurologic disease

          -  BMI â‰¥ 35

          -  Evidence of any of the above by physical examination, ECG or echocardiogram

          -  Smoked cigarette in the past 12 months

          -  History of illicit drug use

          -  Pregnant

          -  Any other condition(s) deemed by the physician investigators that put subjects at
             risk for participating in the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald G Victor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cedars-Sinai Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Havah Jaffe</last_name>
    <phone>3102487641</phone>
    <email>havah.jaffe@cshs.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Havah Jaffe</last_name>
      <phone>310-248-7641</phone>
      <email>havah.jaffe@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Ronald G Victor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>April 30, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
    <investigator_full_name>Ron Victor</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Hookah</keyword>
  <keyword>waterpipe</keyword>
  <keyword>smoking</keyword>
  <keyword>sympathetic</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Smoking</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
